Endoscope Reprocessing Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Endoscope 
Reprocessing Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Acco r d ing  t o  t he  l a t es t  r e po r t  by  I M AR C G r oup ,  t i t l ed  "E ndo scope  Repro cess i ng  
M ar ke t :  G l ob a l  I ndu st ry  T rend s ,  Shar e ,  S i ze ,  G row t h ,  O pp or t u n i t y  and  Fo rec as t  
2024 - 203 2 , "  t he  g lob a l  endo scope  r ep r oce ss ing  m ar ke t  s i ze  r each ed  U S$  2 . 2  B i l l i on  
i n  2 023 .
An  endo scope  r e f e r s  t o  a  m ed ica l  t oo l  t ha t  i s  ge ne r a l l y  us ed  b y  he a l t hc a r e  
Report p r o f ess io na l s  f o r  exam in ing  i n t e r na l  t i s sues  a nd  o r gan s .  I t s  bas i c  des ign  cons i s t s  o f  
an  u m b i l i ca l  o r  u n i ve r sa l  co r d ,  l i g h t  gu ide  co nnec t o r ,  c on t r o l  b ody ,  t he  bend ing  
Highlight and sec t i on  and  i nse r t i on  t ube  w i t h  i n t e r na l  chann e ls  t ha t  conn ec t  t o  t he  v id eo  p r oc esso r t oas s i s t  m ed i ca l  p r o f es s iona l s  i n  p e r f o r m ing  m ino r  su r ge r i es  a nd  im ag ing .  
Howe ve r ,  s i nc e  t he  r i s ks  o f  i n f e c t i on  ass oc ia t ed  w i t h  endo scop es  a r e  h igh  due  t o  
Description t he i r  d i ve r se  u t i l i za t io n  i n  seve r a l  m ed ica l  p r oc edu r e s ,  t h i s  has  im p e l l ed  he a l t hc a r e  
com m i t t e es  t o  im p lem e n t  s t r i c t  en dosc ope  r ep r oces s ing  p r o t o co l s  f o r  m in im iz i ng  t he  
i n f e c t i on  r i s ks . I t  i nc ludes  va r i ous  s t eps  t ha t  en su r e  t he  sa f e t y  o f  pa t i en t s  an d  s t a f f  
wh i l e  l ower in g  t h e  r i s ks  o f  dam ag in g  end oscop es .
Reque st  f o r  a  PDF  sam pl e  o f  t h i s  re por t :  
h t t p s : / / www. im ar c g r ou p . com / end oscop e - r e p r oce ss ing - m a r ke t / r equ es t sa m p le
Report Description
G lo b a l  E n d o s c o p e  R e p r o c e s s i n g  M a r k e t  T r e n d s :
T h e  g l o b a l  m a r k e t  i s  p r i m a r i l y  d r i v e n  b y  t h e  r i s i n g  p r e v a l e n c e  o f  e n d o s c o p y - r e l a t e d  i n f e c t i o n s .  T h i s  i s  s u p p o r t e d  b y  t h e  i n c r e a s i n g  
u t i l i z a t i o n  o f  e n d o s c o p e s  i n  t h e  d i a g n o s i s  a n d  t r e a tm e n t  o f  s e v e r a l  d i s e a s e s .  A l o n g  w i t h  t h i s ,  t h e  g r o w i n g  p r e f e r e n c e  f o r  n o n -
i n v a s i v e  s u r g i c a l  p r o c e d u r e s  h a s  c r e a t e d  t h e  a u g m e n t i n g  n e e d  f o r  e n d o s c o p e s ,  w h i c h ,  i n  t u r n ,  i s  c o n t r i b u t i n g  t o  t h e  m a r k e t .  I n  
l i n e  w i t h  t h i s ,  t h e  r a p i d  o u t b r e a k  o f  c o r o n a v i r u s  d i s e a s e  ( C O V I D - 1 9 )  a c r o s s  t h e  g l o b e  h a s  f u r t h e r  p r o p e l l e d  t h e  d e m a n d  f o r  
e n d o s c o p e  r e p r o c e s s i n g .  
M o r e o v e r ,  n u m e r o u s  i n i t i a t i v e s  u n d e r t a k e n  b y  t h e  g o v e r n m e n t s  o f  s e v e r a l  c o u n t r i e s  f o r  d e v e l o p i n g  m u l t i p l e  t r a i n i n g  p r o g r a m  
i n f r a s t r u c t u r e s  t o  a c h i e v e  h i g h - q u a l i t y  a n d  r e l i a b l e  r e p r o c e s s i n g  p r a c t i c e s  a n d  p r o v i d e  s a m p l e  d o c u m e n t s  t o  h e l p  h e a l t h c a r e  
f a c i l i t i e s  i n  e n d o s c o p e  r e p r o c e s s i n g  a r e  c r e a t i n g  a  p o s i t i v e  m a r k e t  o u t l o o k .  F u r t h e r m o r e ,  c o n t i n u a l  t e c h n o l o g i c a l  a d v a n c e m e n t s ,  
s u c h  a s  t h e  i n t r o d u c t i o n  o f  a u to m a t e d  e n d o s c o p e  p r e p r o c e s s o r s  ( A E R s ) , a r e  p r o v i d i n g  a n  i m p e tu s  t o  t h e  m a r k e t  g r o w t h .  O th e r  
f a c t o r s ,  i n c l u d i n g  t h e  r i s i n g  p e d i a t r i c  p o p u l a t i o n  t h a t  i s  p r o n e  t o  i n f e c t i o n s ,  t h e  i n c r e a s i n g  h e a l t h c a r e  e x p e n d i t u r e  a n d  e x t e n s i v e  
r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s  c o n d u c t e d  b y  k e y  p l a y e r s ,  a r e  a l s o  f a v o r a b l y  i m p a c t i n g  t h e  m a r k e t .
L o o k in g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c ip a t e d  t o  r e a c h  a  v a l u e  o f  U S $  4 . 0  B i l l i o n  b y  2 0 3 2 ,  g r o w in g  a t  a  C A G R  o f  6 . 8 %  d u r i n g  
2 0 2 4 - 2 0 3 2 .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / e n d o s c o p e - r e p r o c e s s i n g - m a r k e t
Breakup by Product:
• High-Level Disinfectants and Test Str ips
• Detergents and Wipes
• Automated Endoscope Reprocessors
• Endoscope Drying, Storage and Transport  
Systems
• Others
Report 
Segmentation Breakup by Process:
• Manual Cleaning
• Automated Cleaning
Breakup by End User:
• Hospitals and Cl inics
• Ambulatory Surgery Centers
• Others
Breakup by Region:
• North America
Report • Asia-Pacifi c
• Europe
Segmentation • Latin America
• Middle East and Afr ica
• Advanced Ster i l i zat ion Products  (ASP)  (Fort ive  
Corporat ion)
• ARC Healthcare Solut ions Inc .
• Bel imed AG (Meta l l  Zug AG)
• BES Rehab Ltd
Competitive • Custom U ltrasonics  Inc.
• Ecolab Inc .
Landscape • ENDO-TECHNIK W. Gr iesat  GmbH (Albyn Medical  
S .L .)
with Key 
• Getinge AB
Players • HOYA Corporat ion
• Metrex Research LLC
• Olympus Corporat ion
• Shinva Medical  Instrument Co.  Ltd.
• Steelco S.p.A.  (Mie le)
• Ster is  p lc .
What was the size of the global endoscope reprocessing 
market in 2023?
What is the expected growth rate of the global 
endoscope reprocessing market during 2024-2032?
What has been the impact of COVID-19 on the global 
endoscope reprocessing market?
Key 
What are the key factors driving the global endoscope 
Questions reprocessing market?
What is the breakup of the global endoscope 
Answered in reprocessing market based on the product?
the Report What is the breakup of the global endoscope reprocessing market based on the process?
What is the breakup of the global endoscope 
reprocessing market based on the end user?
What are the key regions in the global endoscope 
reprocessing market?
Who are the key players/companies in the global 
endoscope reprocessing market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  E n d o s c o p e  R e p r o c e s s i n g  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     H i g h - L e v e l  D i s i n f e c t a n t s  a n d  T e s t  S t r i p s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     D e t e r g e n t s  a n d  W i p e s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     A u t o m a t e d  E n d o s c o p e  R e p r o c e s s o r s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     E n d o s c o p e  D r y i n g ,  S t o r a g e  a n d  T r a n s p o r t  S y s t e m s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     O t h e r s
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  P r o c e s s
    7 . 1     M a n u a l  C l e a n i n g
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     A u t o m a t e d  C l e a n i n g
        7 . 2 . 1  M a r k e t  T r e n d s
Table of         7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     H o s p i t a l s  a n d  C l i n i c s
        8 . 1 . 1  M a r k e t  T r e n d s
Contents         8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     A m b u l a t o r y  S u r g e r y  C e n t e r s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     O t h e r s
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  R e g i o n
    9 . 1     N o r t h  A m e r i c a
        9 . 1 . 1  U n i t e d  S t a t e s
           9 . 1 . 1 . 1  M a r k e t  T r e n d s
           9 . 1 . 1 . 2  M a r k e t  F o r e c a s t
        9 . 1 . 2  C a n a d a
           9 . 1 . 2 . 1  M a r k e t  T r e n d s
           9 . 1 . 2 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. i m a rc g ro u p . c o m / e n d o s c o p e - re p ro c e s s i n g - m a r ke t / t o c
Disclaimer
© 2023  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145 
E-MAIL: [email protected]